Investing in Marijuana Stocks in 2025: What Cannabis Industry Changes Mean for Your Portfolio
In 2025, the cannabis industry is going through a pivotal time, led by crucial regulatory shifts, consolidation, and consistent obstacles around federal legalization in the U.S. Despite the hype in past years, marijuana stocks have experienced prolonged upward movement, with many trading near bottom levels. This drop stems largely from the regulatory holdups at the federal level. Plus, all the high taxes, oversupply in mature markets, and constrained access to traditional banking and capital.
Yet, these headwinds have created a special atmosphere for strategic investors. As the industry develops, companies are cutting costs, merging operations, and concentrating on profitability versus growing too fast. Many U.S. multi-state operators are reporting stronger earnings as they streamline operations and capitalize on efficiencies. The SAFE Banking Act—while still pending—remains a potential catalyst. If passed, it would allow cannabis companies to access standard financial services, boosting legitimacy and institutional investment.
As well as potentially adding much-needed momentum for marijuana stocks to see better trading. When positive news on reform is known, it historically helps how the sector performs. For investors, the current downtrend presents a possibility to find top marijuana stocks to buy. Valuations are lower in comparison to possible earnings growth. Plus, the long-term demand for cannabis—both recreational and medical—continues to expand. Market analysts suggest that the sector is in a consolidation stage. This signal is often a precursor to sustainable development once key legislative or financial barriers are lifted. Below are several marijuana stocks to watch as these market changes further develop.
Marijuana Stocks For Investors 2025 Watchlist
- Canopy Growth Corporation. (NASDAQ:CGC)
- Tilray Brands, Inc. (NASDAQ:TLRY)
- Cronos Group Inc. (NASDAQ:CRON)
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. 
On July 10th, the company announced a strategic partnership to advance staff safety in healthcare. The partnership is designed to ensure a seamless experience for customers, who will be able to continue using the staff safety system they know and trust with zero disruption.
[Read More] 3 Marijuana Stocks For The Investor To Consider Before A Recovery
Tilray Brands, Inc.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. 
In recent news, the company announced its fourth quarter and fiscal year 2025 financial results on July 28, 2025. Tilray will host a live conference call, which will be webcast, to discuss these results at 4:30 PM Eastern Time.
[Read More] Best Cannabis REITs for July 2025: High-Yield Picks for Income Investors
Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
The company has announced its continuous growth with its international footprint in Switzerland. So Cronos Group is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market.
Words From The CEO
“We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, President, and CEO, Cronos.’
